Published February 18, 2022 | Version v1
Journal article Open

Cytokines: The Potential biomarker in Sepsis of dog

Authors/Creators

  • 1. Department of Veterinary Clinical Complex (V.M.E.J.), West Bengal University of Animal & Fishery Sciences, Kolkata, India

Description

Sepsis is most important aetiological factor for death in dogs throughout the World. Various
pathophysiological studies indicated that septic shock is occured due to inflammatory
reaction that triggers cellular damage, multiorgan failure, and thereby, death. Cytokines have
an immense role in causing immunological response through its pleiotropic activities.
Generally, cytokines have both pro- as well as anti-inflammatory actions by maintaining
regulatory defense mechanisms through counteracting with invading microorganisms.
Cytokines are the important biomarker to unregulate the immunological functions by
accelerating inflammation related to cellular damaging. In my present study, I correlate the
potential role of cytokines in maintaining tissue-damaging activities in tissues in the dog.

Files

Files (78.0 kB)

Name Size
md5:49a00e7914f24210b32fa5b1eb7c7a68
78.0 kB Download

Additional details

References

  • Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine. 2001;29(7):1303–1310.
  • Blackwelland T. S., Christman J. W. Sepsis and cytokines: current status British Journal of Anaesthesia 1996; 77: 110–117
  • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest. 1992;101(6):1644–1655
  • Cabrera-Perez J, Condotta SA., Badovinac VP., Griffith TS. Impact of sepsis on CD4 T cell immunity. J Leukoc Biol. 2014 Nov; 96(5): 767–777.
  • Court O, Kumar A, Parrillo JE, Kumar A, Crit Care. Clinical review: Myocardial depression in sepsis and septic shock. 2002; 6(6): 500–508
  • James D. Faix. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013 Jan; 50(1): 23–36.
  • Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, Monteiro MLG dos R, dos Reis MA, Corrêa RRM, Celes MRN. Neonatal Sepsis and Inflammatory Mediators Mediators Inflamm. 2014; 2014: 269681
  • Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine. 2003;348(16):1546– 1554
  • Matsumoto H, Ogura H, Shimizu K, Ikeda M, Hirose T, Matsuura H, Kang S, Takahashi K, Tanaka T, Shimazu T. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018; 8: 13995
  • Schulte W, Bernhagen J, Bucala R. 2013. Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View. Mediators Inflamm. 2013; 165974
  • Wang Y, Liu Q, Liu T, Xu X, Gao W, Bai X, Li Z. Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells predicts the development of sepsis in severe trauma patients: A prospective observational study Medicine (Baltimore) 2018 Feb; 97(8): e9859